In recent years, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have attracted attention as a new option for PCOS treatment, and are currently recommended by the European Society of Endocrinology for treating this patient population [26]. The gene discussed is GCG; the disease is polycystic ovary syndrome.